NL8002071A - 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)- benzoee- zuurderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten. - Google Patents

2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)- benzoee- zuurderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten. Download PDF

Info

Publication number
NL8002071A
NL8002071A NL8002071A NL8002071A NL8002071A NL 8002071 A NL8002071 A NL 8002071A NL 8002071 A NL8002071 A NL 8002071A NL 8002071 A NL8002071 A NL 8002071A NL 8002071 A NL8002071 A NL 8002071A
Authority
NL
Netherlands
Prior art keywords
hydroxy
ethyl
piperazinyl
methyl
benzoic acid
Prior art date
Application number
NL8002071A
Other languages
English (en)
Dutch (nl)
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of NL8002071A publication Critical patent/NL8002071A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
NL8002071A 1979-05-04 1980-04-09 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)- benzoee- zuurderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten. NL8002071A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/036,244 US4255575A (en) 1979-05-04 1979-05-04 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives
US3624479 1979-05-04

Publications (1)

Publication Number Publication Date
NL8002071A true NL8002071A (nl) 1980-11-06

Family

ID=21887503

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8002071A NL8002071A (nl) 1979-05-04 1980-04-09 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)- benzoee- zuurderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten.

Country Status (21)

Country Link
US (1) US4255575A (de)
JP (1) JPS55147262A (de)
AT (1) AT376426B (de)
AU (1) AU531738B2 (de)
BE (1) BE883086A (de)
CA (1) CA1138457A (de)
CH (1) CH645368A5 (de)
DE (1) DE3014813A1 (de)
DK (1) DK159435C (de)
ES (1) ES8104995A1 (de)
FR (1) FR2455590A1 (de)
GB (1) GB2053897B (de)
IE (1) IE49549B1 (de)
IL (1) IL59596A (de)
IT (1) IT1143190B (de)
NL (1) NL8002071A (de)
NO (1) NO152698C (de)
NZ (1) NZ193107A (de)
PH (1) PH17089A (de)
SE (1) SE447109B (de)
ZA (1) ZA801453B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3400168A1 (de) * 1984-01-04 1985-07-11 Bayer Ag, 5090 Leverkusen 5-halogenalkyl-1,3,4-thiadiazol-2-yloxyacetamide
US4616017A (en) * 1984-06-04 1986-10-07 Merck & Co., Inc. Aminohydroxypropoxy substituted aryl compounds
DE3505425A1 (de) * 1985-02-16 1986-08-21 Bayer Ag, 5090 Leverkusen 5-chlor-1,3,4-thiadiazol-2-yloxy-acetamide
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
US4956302A (en) 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
DE3812755A1 (de) * 1988-04-16 1989-10-26 Merck Patent Gmbh Salicylsaeurederivate
KR100484386B1 (ko) * 2000-10-04 2005-04-22 경동제약 주식회사 알킬2-[2,3,5-트리플루오로-4-(4-메틸-1-피페라지닐)]벤조일-3(s)-(1-히드록시프로피-2-닐아미노)아크릴레이트의 제조방법
US20080131954A1 (en) * 2006-11-30 2008-06-05 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317479A (en) * 1970-11-10 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
CA1113937A (en) * 1977-04-05 1981-12-08 Frederic P. Hauck Substituted piperidinylpropanols

Also Published As

Publication number Publication date
US4255575A (en) 1981-03-10
ES490667A0 (es) 1981-05-16
NO801297L (no) 1980-11-05
JPS6321666B2 (de) 1988-05-09
DK159435B (da) 1990-10-15
AT376426B (de) 1984-11-26
PH17089A (en) 1984-05-29
NZ193107A (en) 1982-12-21
ATA232580A (de) 1984-04-15
IE800481L (en) 1980-11-04
AU531738B2 (en) 1983-09-01
IL59596A (en) 1984-01-31
NO152698B (no) 1985-07-29
ES8104995A1 (es) 1981-05-16
ZA801453B (en) 1980-12-31
SE8003244L (sv) 1980-11-05
FR2455590A1 (fr) 1980-11-28
DE3014813A1 (de) 1980-11-13
BE883086A (fr) 1980-09-01
FR2455590B1 (de) 1983-10-14
GB2053897A (en) 1981-02-11
IT1143190B (it) 1986-10-22
CH645368A5 (de) 1984-09-28
JPS55147262A (en) 1980-11-17
DK159435C (da) 1991-03-25
AU5707680A (en) 1980-11-06
DK193680A (da) 1980-11-05
CA1138457A (en) 1982-12-28
IE49549B1 (en) 1985-10-30
SE447109B (sv) 1986-10-27
IL59596A0 (en) 1980-06-30
IT8048267A0 (it) 1980-03-26
NO152698C (no) 1985-11-20
GB2053897B (en) 1982-10-20

Similar Documents

Publication Publication Date Title
DE69815008T2 (de) Alfa-substituierte Phenylpropionsäurederivate und diese enthaltende Arzneimittel
US5206366A (en) Process for preparing aryl piperazinyl-heterocyclic compounds
JP2637737B2 (ja) 新規な薬剤
FR2501690A1 (fr) Derives heterocycliques du type 1,2,4-triazole, leur preparation et leur application pharmacologique
JPH0647586B2 (ja) 1−ヘテロアリ−ル−4−〔(2.5−ピロリジンジオン−1−イル)アルキル〕ピペラジン誘導体
LU85442A1 (fr) Agents antidepression a base de 1,2,4-triazol-3-one
US5225409A (en) Benzoxazinone compounds
US5710152A (en) Benzoazine derivative or salt thereof and pharmaceutical compostion comprising the same
JPS6012350B2 (ja) 新規アリ−ルピペリジン誘導体の製造方法
JPH0229671B2 (de)
CA2087855A1 (en) 1,4-disubstituted piperazines
FR2628425A1 (fr) Derives d'isoindolinone, leurs procedes de preparation et les medicaments les contenant
NL8002071A (nl) 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)- benzoee- zuurderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten.
US4337343A (en) 4,5 or 6-Alkylaminoalkyl-2-alkyl-4,5,6,7-tetrahydro benzo[d]thiazoles
US5084456A (en) Oxazolopyridine compounds
KR0145337B1 (ko) 의식장해 개선제, 중추신경계 부활제 또는 시그마 수용기 작동제용 카르보스티릴 유도체 및 이것을 함유하는 약학 조성물
PL179032B1 (pl) kwasu hydroksamowego oraz kompozycje farmaceutyczne zawierajace nowe pochodnekwasu hydroksamowego PL PL
SE446980B (sv) Alkyltiofenoxialkylaminer samt forfarande for framstellning derav
US4474783A (en) Cyclopropylmethyl piperazines, the process for preparing the same and their use in therapeutics
CA1132983A (fr) Procedes de preparation de nouvelles piperazines monosubstituees
NL8203035A (nl) Spirothiazolidinylpiperazinederivaten.
JPH069588A (ja) ピペラジン誘導体
US4206217A (en) 3-[4-(1,3-Diazacycloalken-2-yl)-phenyl]-1,2-benzisothiazoles, their manufacture, and drugs containing these compounds
CH652119A5 (fr) Derives de l'acide guanidinocyclohexanecarboxylique et leur procede de fabrication.
JPS6130588A (ja) ベンゾ〔c〕〔1,8〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed